Trace Neuroscience

South San Francisco, United States

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

$101.0M raised

Nov 2024

Series A

Biotechnology Health Care Life Science Neuroscience

Top Investors

RA Capital ManagementThird Rock VenturesAtlas VentureGV

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trace Neuroscience

How much funding has Trace Neuroscience raised?

Trace Neuroscience has raised $101.0M in total funding. The most recent round was Series A. The last funding was announced in November 2024.

Who are Trace Neuroscience's investors?

Trace Neuroscience's investors include RA Capital Management, Third Rock Ventures, Atlas Venture, GV.

Where is Trace Neuroscience headquartered?

Trace Neuroscience is headquartered in South San Francisco, United States.

What does Trace Neuroscience do?

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

What stage is Trace Neuroscience at?

Trace Neuroscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 12, 2024.

MLA

"Trace Neuroscience — Funding & Investors." VCBacked, November 12, 2024, https://www.vcbacked.co/company/trace-neuroscience. Accessed June 4, 2026.

APA

VCBacked. (2024). Trace Neuroscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/trace-neuroscience

Wikipedia (cite web)

{{cite web |title=Trace Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/trace-neuroscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 12, 2024.

Similar Companies in Biotechnology